eFFECTOR Therapeutics Inc
F:LWK1

Watchlist Manager
eFFECTOR Therapeutics Inc Logo
eFFECTOR Therapeutics Inc
F:LWK1
Watchlist
Price: 9.1 EUR Market Closed
Market Cap: 1.1m EUR

Net Margin
eFFECTOR Therapeutics Inc

0%
Current
-872%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-34.6m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

eFFECTOR Therapeutics Inc
Glance View

Market Cap
1.1m EUR
Industry
Biotechnology

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). The company is headquartered in Solana Beach, California and currently employs 13 full-time employees. The company went IPO on 2021-01-08. The firm is focused on the development of oncology drugs, such as selective translation regulator inhibitors (STRIs). The company uses selective translation regulation technology platform to internally discover a portfolio of small molecule STRI product candidates. Its product candidates target the eIF4F complex and its activating kinase, MNK. The firm's lead product candidate, tomivosertib, is an inhibitor of MNK, and is being evaluated in combination with KEYTRUDA (pembrolizumab), an inhibitor of programed cell death protein 1 (PD-1) in a randomized Phase IIb clinical trial in patients with metastatic non-small cell lung cancer (NSCLC). Its second product candidate, zotatifin, is an inhibitor of eIF4A, a component of the eIF4F complex, and is being evaluated in a Phase I/II clinical trial in patients with certain solid tumors. Its third program is focused on developing inhibitors of eIF4E.

LWK1 Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-34.6m
/
Revenue
0
What is the Net Margin of eFFECTOR Therapeutics Inc?

Based on eFFECTOR Therapeutics Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top